CANDEL THERAPEUTICS, INC. (CADL) Operating cash flow 2020–2025
CANDEL THERAPEUTICS, INC. (CADL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$38.3MFY2025 · since FY2020: -$9.1M → -$38.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.3M | -41.8% |
| FY2024 | -$27.0M | +21.1% |
| FY2023 | -$34.2M | -9.0% |
| FY2022 | -$31.4M | -41.4% |
| FY2021 | -$22.2M | -144.9% |
| FY2020 | -$9.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice